What to Know About GlaxoSmithKline plc (ADR) (GSK)
This money coming in is cash flow, and looking at a company's cash flow gives us -- as current or potential shareholders -- a sense of how well that company is doing at selling...
Posts Tagged ‘NYSE:GSK’
AstraZeneca plc (ADR) (AZN)’s Acquisition of Omthera Pharmaceuticals Inc (OMTH) Is a Desperate Act
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Should You Buy AstraZeneca plc (ADR) (AZN)?
Is AstraZeneca plc (ADR) (NYSE:AZN) a healthy stock for your portfolio? Investors who are in the know are getting more bullish.
Sarissa’s Stake in Vivus, Inc. (VVUS) Points to Renewed Interest in the Company
Noted hedge fund Sarissa Capital Management recently disclosed a stake of nearly 2% in promising biotechnology firm VIVUS, Inc. (NASDAQ:VVUS) .
Pfizer Inc. (PFE)’s Big Chance
When we think of big pharma companies, the company we think about constantly is Pfizer Inc.
How AstraZeneca plc (ADR) (AZN) Measures Up as a GARP Investment
LONDON -- A popular way to dig out reasonably priced stocks with robust growth potential is through the "Growth at a Reasonable Price," or GARP, strategy.
Merck & Co., Inc. (MRK), Celgene Corporation (CELG): 3 FDA Stories You Missed Last Week
Editor's Note: The initial article refers to Abraxane's prostate cancer trials. That is incorrect, Abraxane has priority review for pancreatic cancer.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK): Three FDA Stories You Missed Last Week
The Food and Drug Administration stays busy with approvals, recommendations, and reviews.
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY): Pharma Big Wigs Warm Up to Africa’s $40 Billion Opportunity
For a long time, Africa’s traditional enemy with regard to diseases have been communicable diseases like HIV and Malaria. Now, however, this trend is changing.
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
AbbVie Inc (ABBV): Hedge Funds and Insiders Are Bullish, What Should You Do?
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
Does Novartis AG (ADR) (NVS) Pass Buffett’s Test?
We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more.
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): 5 Costliest Microbes in Financial History
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
Compass Group plc (CPG), ARM Holdings plc (ADR) (ARMH), GlaxoSmithKline plc (ADR) (GSK): 3 Shares to Gain From Powerful Global Trends
LONDON -- The economic crisis has forced governments worldwide to consider how they can deliver services more efficiently. Frequently, they are turning to the private sector.
GlaxoSmithKline plc (GSK): The Perfect Tonic for Troubled Markets
LONDON -- If you can keep your head while everyone around is losing theirs, you probably hold shares in GlaxoSmithKline plc (LON:GSK).
Hedge Funds Are Dumping GlaxoSmithKline plc (ADR) (GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) was in 18 hedge funds' portfolio at the end of March. GSK investors should be aware of a decrease in enthusiasm from smart money lately.
General Electric Company (GE) Vs Two Alternatives
General Electric Company (NYSE:GE) steadily pays out dividends to its shareholders. The payout amount has been increasing year over year for three years in a row.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) Are NOT The Newest Obesity Drug Player
VIVUS, Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals, Inc.
Three Things About to Move Pfizer Inc. (PFE) Stock
Large, multinational companies have an unprecedented number of things pulling and pushing on their share price.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): Tuesday’s Top Upgrades & Downgrades
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.
Vodafone Group Plc (ADR) (VOD), GlaxoSmithKline plc (ADR) (GSK), Anheuser-Busch InBev NV (ADR) (BUD): German, French Indices Vulnerable at Elevated Levels
The Eurozone debt problems have held as a central focus of the financial markets since 2010.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY), AbbVie Inc (ABBV): The 5 Highest-Paying Dividend Stocks in Big Pharma
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Three Reasons to Love GlaxoSmithKline plc (GSK)
LONDON -- It's been a long tough slog for GlaxoSmithKline plc (LON:GSK) shares, but things are looking up.
GlaxoSmithKline plc (ADR) (GSK), ConocoPhillips (COP): Buffett’s Favorite Yielders
TheStreet.com recently ran an article outlining five companies that Warren Buffett holds in his portfolio that yield 3% or better.
GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc (THRX): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK): The U.S.’s Deadliest Diseases
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Is Gilead Sciences, Inc. (GILD) Still A Buy?
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership?
Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies.
3 FTSE 100 Shares Hitting New Highs: GlaxoSmithKline plc (GSK), BT Group plc (BT.A), British American Tobacco plc (BATS)
LONDON -- The FTSE 100 set a five-and-a-half-year record of 6,638 points last Friday, and though the index is down from that today at 6,617, it still looks like hanging on to...
Pfizer Inc. (PFE): Speculation Sickens Dow Jones Industrial Average (.DJI), Pharma Tries to Cure It
Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher.
Amarin Corporation plc (ADR) (AMRN) & More: Who’s Being Tested?
A study published in The New England Journal of Medicine testing omega-3 fatty acids -- commonly found in fish oil -- in patients with risk factors for cardiovascular disease ...
GlaxoSmithKline plc (ADR) (GSK), Eli Lilly & Co. (LLY): This Week in Biotech
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
GlaxoSmithKline plc (ADR) (GSK): A Look At Its Dividend History
LONDON -- Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.
Sarepta Therapeutics Inc (SRPT): Sad Trombone?
The words of the great big-band leader Duke Ellington came to mind after hearing the first quarter results from Sarepta Therapeutics Inc (NASDAQ:SRPT) : "It don't mean a thing...
Wal-Mart Stores, Inc. (WMT), The Coca-Cola Company (KO), 3M Co (MMM): Buy Individual Stocks Instead of Dividend ETFs
Exchange-traded funds are all the rage these days, and for good reason.
GlaxoSmithKline plc (ADR) (GSK): Why Investors Should Consider It
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Theravance Inc (THRX), Sterling Bancorp (STL): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Onyx Pharmaceuticals, Inc. (ONXX), Pfizer Inc. (PFE), And Kidney Cancer’s Top Bets
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX): Take a Deep Breath Before This Big FDA Decision
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
GlaxoSmithKline plc (GSK), Antofagasta plc (ANTO), Kingfisher plc (KGF): Three FTSE 100 Shares Going Ex-Dividend Next Week
LONDON -- If you want to be eligible for a dividend payment, or if you're hoping a share price might drop disproportionately when the time has passed, you need to be aware of ...
Merck & Co., Inc. (MRK) Down, Could’ve Fallen Worse
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
